The first thing to know is: The COVID vaccines are safe, effective, and necessary. Doctors recommend them and the vaccines are available to everyone ages 12 and older in New York state.
Jun 8, 2021
0
7
A superficial reading of the history of vaccination might lead you to believe that it is simple. Dried smallpox pustules had been used for 1,000 years to inoculate people against smallpox before the first successful vaccine ...
May 20, 2021
0
5
(HealthDay)—The B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not associated with more severe illness or death but leads to higher viral load and is associated with increased R1, according ...
Apr 14, 2021
0
4
Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared ...
Apr 13, 2021
0
94
Researchers have developed the first report card on biosimilars for three blockbuster cancer drugs marketed by Genentech/Roche: Rituxan, Avastin and Herceptin. In a Policy Review in The Lancet Oncology, Y. Tony Yang, a professor ...
Dec 1, 2020
0
0
Scientists from the University of Oxford, working as part of the EBOVAC2 EBL2001 study group, have today announced the results of a phase 2 trial of a replication-deficient adenovirus vaccine aimed at providing protection ...
Nov 18, 2020
0
8
The prestigious Lancet medical journal said it is bolstering its scientific review process after being forced to retract a study into the effects of an anti-arthritis drug on COVID-19 patients.
Sep 18, 2020
0
51
The Lancet medical journal said Thursday it had asked authors of a study on a potential Russian COVID-19 vaccine for clarifications after their research came under scrutiny.
Sep 10, 2020
0
4
Test and trace could reduce the effective reproduction number, the R number, by up to 26% if carried out quickly and effectively, new research finds.
Aug 19, 2020
0
152
New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues as to why they experienced a high death rate of 33% when the coronavirus swept across Europe.
Jun 16, 2020
0
1
